European journal of pharmacologyHumansMaltoseHeart FailureFerric CompoundsRandomized Controlled Trials as Topic
Intravenous ferric carboxymaltose for iron deficiency in heart failure patients: A meta-analysis with trial sequential analysis.
Laila Shalabi, Ahmed Ibrahim, Shrouk Ramadan, Sofian Zreigh, Shahed Shalabi, Mohamed Rifai, Abdelaziz A Awad, Abdelrahman Mamdouh Ahmed, Matthieu Legrand, Dan Meyer
Published: 202510.1016/j.ejphar.2025.178314
Abstract
BACKGROUND: Iron deficiency is present in roughly one-third to one-half of patients with chronic heart failure and is associated with worse outcomes. In this study, we aim to assess the impact of intravenous (IV) ferric carboxymaltose (FCM) administr…
Preview only. Read the full abstract at the source